Involvement of ERK1/2, p38 and PI3K in megakaryocytic differentiation of K562 cells

European Journal of Haematology

Volumn 84, Issue 5, 2010, Pages 430-440

  Conde, Isabel ^a   Pabón, Dina ^a   Jayo, Asier ^a   Lastres, Pedro ^a   Gonzalez Manchon, Consuelo ^a,b  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Extracellular signal regulated protein kinase; K562; Megakaryocytic differentiation; P38; Phosphoinositide 3 kinase

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; GLYCOPROTEIN IB ALPHA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLINOSITOL 3 KINASE; STAUROSPORINE;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN K 562; CONTROLLED STUDY; DOWN REGULATION; ENDOREDUPLICATION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIFFERENTIATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; IMIDAZOLES; K562 CELLS; MEGAKARYOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; POLYPLOIDY; PROTEIN KINASE INHIBITORS; PYRIDINES; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE;

EID: 77951087950     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2010.01416.x     Document Type: Article

References (47)

1. Kirito K, Kaushansky K. Transcriptional regulation of megakaryopoiesis: thrombopoietin signaling and nuclear factors. Curr Opin Hematol 2006 13 : 151 156.
2. Szalai G, LaRue AC, Watson DK. Molecular mechanisms of megakaryopoiesis. Cell Mol Life Sci 2006 63 : 2460 2476.
3. Debili N, Kieffer N, Nakazawa M, Guichard J, Titeux M, Cramer E, Breton-Gorius J, Vainchenker W. Expression of platelet glycoprotein Ib in cultured human megakaryocytes: ultrastructural localization and biosynthesis. Blood 1990 15 : 368 376.
4. Okumura N, Tsuji K, Nakahata T. Changes in cell surface antigen expression during proliferation and differentiation of human erythroid progenitors. Blood 1992 80 : 642 650.
5. + cord blood cells to megakaryocytes. Blood 2000 96 : 4169 4177.
6. Goldfarb AN. ERK expands its empire. Leuk Res 2005 29 : 1235 1236.
7. Rojnuckarin P, Drachman JG, Kaushansky K. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: role in endomitosis. Blood 1999 94 : 1273 1282.
8. García J, de Gunzburg J, Eychène A, Gisselbrecht S, Porteu F. Thrombopoietin-mediated sustained activation of extracellular signal-regulated kinase in UT7-Mpl cells requires both Ras-Raf 1 and Rap1-B Raf-dependent pathways. Mol Cell Biol 2001 21 : 2659 2670.
9. Tang YS, Zhang YP, Xu P. hNUDC promotes the cell proliferation and differentiation in a leukemic cell line via activation of the thrombopoietin receptor (Mpl). Leukemia 2008 22 : 1018 1025.
10. Mazharian A, Watson SP, Séverin S. Critical role of ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation. Exp Hematol 2009 37 : 1238 1249.
11. Melemed AS, Ryder JW, Terry AV. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells. Blood 1997 90 : 3462 3470.
12. Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS, Ahn NG. Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase. Mol Cell Biol 1997 17 : 1947 1958.
13. Ajenjo N, Aaronson DS, Ceballos E, Richard C, León J, Crespo P. Myeloid leukemia cell growth and differentiation are independent of mitogen-activated protein kinase ERK1/2 activation. J Biol Chem 1999 275 : 7189 7197.
14. Geddis AE, Fox NE, Kaushansky K. Phosphatidylinositol 3-kinase is necessary but not sufficient for thrombopoietin-induced proliferation in engineered Mpl-bearing cell lines as well as in primary megakaryocytic progenitors. J Biol Chem 2001 276 : 34473 34479.
15. Rojnuckarin P, Miyakawa Y, Fox NE, Deou J, Daum G, Kaushansky K. The roles of phosphatidylinositol 3-kinase and protein Czeta for thrombopoietin-induced mitogen-activated protein kinase activation in primary murine megakaryocytes. J Biol Chem 2001 276 : 41014 41022.
16. Guerriero R, Parolini I, Testa U, Samoggia P, Petrucci E, Sargiacomo M, Chelucci C, Gabbianelli M, Peschle C. Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes. J Cell Sci 2006 119 : 744 752.
17. Charney P, Maniatis T. Transcriptional regulation of globin gene expression in the human erythroid cell line K562. Science 1983 220 : 1281 1283.
18. Shelly C, Petruzzelli L, Herrera R. PMA-induced phenotypic changes in K562 cells: MAPK-dependent and-independent events. Leukemia 1998 12 : 1951 1961.
19. Racke FK, Lewandowska K, Goueli S, Goldfarb AN. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 1997 272 : 23366 23370.
20. Jacquel A, Herrant M, Defamie V, et al. A survey of the signaling pathways involved in megakaryocytic differentiation of the human K562 leukemia cell line by molecular and c-DNA array analysis. Oncogene 2006 25 : 781 794.
21. Butta N, Arias-Salgado EG, González-Manchón C, Ferrer M, Larrucea S, Ayuso MS, Parrilla R. Disruption of the β3 663-687 disulfide bridge confers constitutive activity to β3 integrins. Blood 2003 102 : 2491 2497.
22. Lerga A, Crespo P, Berciano M, et al. Regulation of c-Myc and Max in megakaryocytic and monocytic-macrophagic differentiation of K562 cells induced by protein kinase C modifiers: c-Myc is down-regulated but does not inhibit differentiation. Cell Growth Differ 1999 10 : 639 654.
23. Shelly C, Petruzzelli L, Herrera R. K562 cells resistant to phorbol 12-myristate 13 acetate-induced growth arrest: dissociation of mitogen-activated protein kinase activation and Erg-1 expression from megakaryocyte differentiation. Cell Growth Differ 2000 11 : 501 506.
24. Borsh-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB203580 and PD98059. J Biol Chem 1998 273 : 28766 28772.
25. Jacob A, Cooney D, Pradhan M, Coggeshall KM. Convergence of signaling pathways on the activation of ERK in B cell. J Biol Chem 2002 277 : 23420 23426.
26. Romano D, Pertruit M, Rasonlojanahary R, Barnier JV, Magalon K, Enjalbert A, Gerard C. Regulation of the RAP1/RAF-1/extracellular regulated kinase-1/2 cascade and prolactin release by the phosphoinositide 3-kinase/AKT pathway in pituitary cells. Endocrinology 2006 147 : 6036 6045.
27. Wiseman JC, Ma LL, Marr KJ, Jones CJ, Mody CH. Perforin-dependent cryptococcal microbicidal activity in NK cells requires PI3K-dependent ERK1/2 signaling. J Immunol 2007 178 : 6456 6464.
28. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 2000 351 : 95 105.
29. Ge B, Gram H, Di Padova F, Huamg B, New L, Ulevitch RJ, Luo Y, Han J. MAPKK-independent activation of p38α mediated by TAB 1-dependent autophosphorylation of p38α. Science 2002 295 : 1291 1294.
30. Wada T, Penninger JM. Mitogen-acivated protein kinases in apoptosis regulation. Oncogene 2004 23 : 2838 2849.
31. Ogura M, Morishima Y, Ohno R, Kato Y, Hirabayashi N, Nagura H, Saito H. Establishment of a novel human megakaryoblastic leukemia cell line, MEG-01, with positive Philadelphia chromosome. Blood 1985 66 : 1384 1392.
32. Bennett JS, Vilaire G, McDonough M, Silver SM. Glycoproteins IIb and IIIa in K562 cells. Response. Blood 1988 71 : 1172.
33. Kieffer N, Wautier JL, Coulombel L, Titeux M, Wautier MP, Vainchenker W, Ruan C, Breton-Gorius J. Uncoupling in the expression of platelet GPIIb/IIIa in human endothelial cells and K562 cells: absence of immunologic crossreactivity between platelet GPIIb and the vitronectin receptor alpha chain. Blood 1988 72 : 1209 1215.
34. Yen A, Varvayanis S, Platko JD. 12-O-tetradecanoylphorbol-13-acetate and staurosporine induce increased retinoblastoma tumor suppressor gene expression with megakaryocytic differentiation of leukemia cell. Cancer Res 1993 53 : 3085 3091.
35. Rubin CI, French DL, Atweh GF. Stathmin expression and megakaryocyte differentiation: a potential role in polyploidy. Exp Hematol 2003 31 : 389 397.
36. Miyakawa Y, Rojnuckarin P, Habbit T, Kaushansky K. Thrombopoietin induces phosphoinositol 3-kinase activation through SHP2, Gab, and insulin receptor substrate proteins in BAF3 cells and primary murine megakaryocytes. J Biol Chem 2001 276 : 2494 2502.
37. Ravid K, Lu J, Zimmet JM, Jones MR. Roads to polyploidy: the megakaryocyte example. J Cell Physiol 2002 190 : 7 20.
38. Bulavin DV, Fornace AJ Jr. p38 MAP kinase's emerging role as a tumor suppressor. Adv Cancer Res 2004 92 : 95 118.
39. Hui L, Bakiri L, Stepniak E, Wagner EF. p38alpha: a suppressor of cell proliferation and tumorigenesis. Cell Cycle 2007 6 : 2429 2433.
40. Tsiftsoglou AS, Pappas IS, Vizirianakis IS. Mechanisms involved in the induced differentiation of leukemia cells. Pharmacol Ther 2003 100 : 257 290.
41. De Botton S, Sabri S, Daugas E, Zermati Y, Guidotti JE, Hermine O, Kroemer G, Vainchenker W, Debili N. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood 2002 100 : 1310 1317.
42. Clarke MCH, Savill J, Jones DB, Noble BS, Brown SB. Compartmentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol 2003 160 : 577 587.
43. Porras A, Zuluaga S, Black E, Valladares A, Álvarez AM, Ambrosino C, Benito M, Nebreda AR. p38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell 2004 15 : 922 933.
44. Wang D, Li H, Yuan H, Zheng M, Bai C, Chen L, Pei X. Humanin delays apoptosis in K562 cells by downregulation of p38 MAP kinase. Apoptosis 2005 10 : 963 971.
45. Zhang X, Shan P, Otterbein LE, Alam J, Flavell RA, Davis RJ, Choi AMK, Patty JL. Carbon monoxide inhibition of apoptosis during ischemia-reperfusion lung injury is dependent on the p38 mitogen-activated protein kinase pathway and involves caspase 3. J Biol Chem 2003 278 : 1248 1258. (Pubitemid 36790808)
46. Yosimichi G, Nakanishi N, Nishida T, Hattori T, Takano-Yamamoto T, Takigawa M. CTGF/Hcs24 induces chondrocyte differentiation through a p38 mitogen-activated protein kinase (p38MAPK), and proliferation through a p44742 MAPK/extracellular-signal regulated kinase (ERK). Eur J Biochem 2001 268 : 6058 6065.
47. Jaquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S, Breittmayer JP, Auberger P. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Oncogene 2007 26 : 2445 2458.